Cordova Ashley - Feb 27, 2025 Form 4/A - Amendment Insider Report for NovoCure Ltd (NVCR)

Signature
Steven Robbins, as attorney in fact for Cordova, Ashley
Stock symbol
NVCR
Transactions as of
Feb 27, 2025
Transactions value $
-$266,126
Form type
4/A - Amendment
Date filed
3/3/2025, 09:26 PM
Date Of Original Report
Mar 3, 2025
Previous filing
Jan 3, 2025
Next filing
Mar 4, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale -$186K -9.35K -4.26% $19.92 210K Feb 27, 2025 Direct F1, F2
transaction NVCR Ordinary Shares Sale -$37.2K -1.81K -0.86% $20.55 208K Feb 27, 2025 Direct F1, F3
transaction NVCR Ordinary Shares Sale -$42.8K -2.34K -1.12% $18.28 206K Feb 28, 2025 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 On February 27, 2025, the reporting person sold 9,345 shares in multiple trades at prices ranging from $19.41 to $20.4033. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F3 On February 27, 2025, the reporting person sold 1,808 shares in multiple trades at prices ranging from $20.41 to $20.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F4 On February 28, 2025, the reporting person sold 2,341 shares in multiple trades at prices ranging from $18.175 to $18.765. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

Amended to add footnote #1 to the filing.